Gyre Therapeutics (GYRE) Receivables - Other (2012 - 2026)
Gyre Therapeutics (GYRE) reported Receivables - Other of $200000.0 for Q1 2026, little changed year-over-year from $200000.0 in Q1 2025, and little changed quarter-over-quarter from $200000.0 in Q4 2025.
Gyre Therapeutics (GYRE) Receivables - Other (2012 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has 7 years of Receivables - Other data on file, last reported at $200000.0 in Q1 2026.
- Receivables - Other for Q1 2026 came in at $200000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $200000.0 (changed 0.0% YoY), and the FY2025 annual result was $200000.0, down 13.04% from the prior year.
- Receivables - Other held at $200000.0 in Q1 2026 per GYRE's latest filing, from $200000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $1.2 million in Q3 2023 and troughed at $200000.0 in Q1 2025.
- A 4-year average of $444166.7 and a median of $265000.0 in 2023 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other jumped 66.67% in 2024, then plunged 75.0% in 2025.
- A 4-year view of Receivables - Other shows it stood at $800000.0 in 2023, then slumped by 71.25% to $230000.0 in 2024, then fell by 13.04% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
- Business Quant data shows GYRE's Receivables - Other at $200000.0 in Q1 2026, $200000.0 in Q4 2025, and $200000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 230,000.00 |
| Dec 31, 2024 | 230,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Dec 31, 2023 | 800,000.00 |